9 Meters Biopharma Announces Agreement with the European Biomedical Research Institute of Salerno (EBRIS) to Continue Evaluation of Larazotide for COVID-19 Respiratory Complications 9 Meters Biopharma, Inc. (NASDAQ: NMTR) announces agreement with the European Biomedical Research Institute of Salerno (EBRIS) to continue evaluation of larazotide for COVID-19 respiratory complicationsREAD MORE Read More Intuitive Venture PartnersDecember 21, 20209 Meters, 2020
9 Meters Biopharma, Inc. Announces Closing of Offering of Common Stock 9 Meters Biopharma, Inc. (NASDAQ: NMTR) announces closing of offering of common stockREAD MORE Read More Intuitive Venture PartnersDecember 15, 20209 Meters, 2020
9 Meters Biopharma, Inc. Announces Proposed Public Offering of Common Stock 9 Meters Biopharma, Inc. (NASDAQ: NMTR) announces proposed public offering of common stockREAD MORE Read More Intuitive Venture PartnersDecember 10, 20209 Meters, 2020
